TY  - GEN
AU  - Dang,Nam H
AU  - Fayad,Luis
AU  - McLaughlin,Peter
AU  - Romaguara,Jorge E
AU  - Hagemeister,Fredrick
AU  - Goy,Andre
AU  - Neelapu,Sattva
AU  - Samaniego,Felipe
AU  - Walker,Pamela L
AU  - Wang,Michael
AU  - Rodriguez,Maria A
AU  - Tong,Ann T
AU  - Pro,Barbara
TI  - Phase II trial of the combination of denileukin diftitox and rituximab for relapsed/refractory B-cell non-Hodgkin lymphoma
SN  - 0007-1048
PY  - 2007///0928
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - therapeutic use
KW  - Antibodies, Monoclonal, Murine-Derived
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Diphtheria Toxin
KW  - Female
KW  - Humans
KW  - Interleukin-2
KW  - Lymphoma, B-Cell
KW  - drug therapy
KW  - Lymphoma, Follicular
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Recombinant Fusion Proteins
KW  - Recurrence
KW  - Rituximab
KW  - Time Factors
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/j.1365-2141.2007.06684.x
ER  -